Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 13 04:00PM ET
2.36
Dollar change
-0.05
Percentage change
-2.07
%
Index- P/E- EPS (ttm)-5.87 Insider Own11.73% Shs Outstand1.33M Perf Week-0.42%
Market Cap3.07M Forward P/E- EPS next Y-7.28 Insider Trans0.00% Shs Float1.18M Perf Month-20.54%
Income-4.68M PEG- EPS next Q-1.36 Inst Own3.20% Short Float2.79% Perf Quarter-51.93%
Sales0.00M P/S- EPS this Y19.43% Inst Trans14.43% Short Ratio0.31 Perf Half Y-60.37%
Book/sh2.82 P/B0.84 EPS next Y-28.99% ROA-105.77% Short Interest0.03M Perf Year-85.91%
Cash/sh2.32 P/C1.02 EPS next 5Y- ROE-119.56% 52W Range1.62 - 23.50 Perf YTD-83.58%
Dividend Est.- P/FCF- EPS past 5Y-2.02% ROI-149.22% 52W High-89.96% Beta1.33
Dividend TTM- Quick Ratio7.27 Sales past 5Y0.00% Gross Margin- 52W Low45.68% ATR (14)0.38
Dividend Ex-Date- Current Ratio7.27 EPS Y/Y TTM57.50% Oper. Margin- RSI (14)40.10 Volatility10.81% 18.96%
Employees4 Debt/Eq0.00 Sales Y/Y TTM- Profit Margin- Recom2.00 Target Price25.00
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q41.43% Payout- Rel Volume0.05 Prev Close2.41
Sales Surprise- EPS Surprise-74.22% Sales Q/Q- EarningsNov 07 BMO Avg Volume107.22K Price2.36
SMA20-6.24% SMA50-31.34% SMA200-62.11% Trades Volume4,931 Change-2.07%
Nov-18-24 08:45AM
Nov-08-24 02:35AM
02:15AM
Nov-07-24 07:05AM
Oct-31-24 09:15AM
09:15AM Loading…
Oct-30-24 09:15AM
Oct-08-24 08:29AM
Oct-07-24 07:05AM
Aug-08-24 09:15AM
Aug-01-24 09:41AM
Jul-23-24 09:15AM
May-22-24 01:30PM
May-20-24 02:19PM
10:25AM
09:20AM
07:36AM Loading…
07:36AM
03:54AM
May-19-24 08:53PM
May-17-24 04:10PM
May-13-24 10:49AM
May-09-24 07:45AM
May-02-24 09:15AM
Mar-26-24 09:15AM
Feb-29-24 09:15AM
Feb-28-24 09:15AM
Jan-22-24 09:00AM
Jan-02-24 07:05AM
Nov-14-23 09:55AM
Nov-13-23 07:05AM
Nov-06-23 07:05AM
07:05AM Loading…
Oct-12-23 07:05AM
Sep-18-23 07:05AM
Sep-12-23 07:05AM
Aug-15-23 07:48AM
Aug-14-23 07:05AM
Aug-12-23 09:40AM
Aug-10-23 07:05AM
Aug-09-23 07:05AM
Aug-03-23 04:05PM
Jul-24-23 08:40AM
Jul-17-23 02:20PM
07:05AM
May-25-23 04:05PM
May-16-23 10:26AM
May-15-23 07:05AM
May-11-23 07:49AM
07:39AM
07:05AM
May-04-23 07:05AM
Apr-25-23 01:07PM
Apr-24-23 04:15PM
Mar-16-23 07:10AM
Mar-14-23 07:05AM
Mar-07-23 07:05AM
Feb-13-23 07:05AM
Jan-05-23 07:00AM
Dec-05-22 08:30AM
Nov-29-22 07:05AM
Nov-22-22 06:15AM
Nov-14-22 07:05AM
Nov-03-22 07:05AM
Sep-23-22 07:27AM
Sep-22-22 04:15PM
Sep-19-22 10:04PM
04:05PM
11:20AM
09:33AM
08:22AM
07:05AM
Sep-16-22 09:30AM
Sep-12-22 09:30AM
Sep-05-22 06:47AM
Aug-15-22 07:24AM
07:05AM
Aug-11-22 07:05AM
Aug-10-22 04:01PM
Aug-08-22 08:30AM
Aug-04-22 07:05AM
Jul-26-22 08:30AM
Jul-19-22 08:30AM
Jun-01-22 07:05AM
May-17-22 12:05PM
May-12-22 07:05AM
May-05-22 07:05AM
Apr-28-22 07:05AM
Mar-28-22 07:10PM
Mar-21-22 06:25AM
Mar-17-22 07:05AM
Mar-10-22 07:05AM
Mar-08-22 04:05PM
Feb-28-22 07:05AM
Feb-01-22 03:00AM
Jan-26-22 04:30PM
Jan-04-22 04:05PM
Dec-01-21 07:05AM
Nov-15-21 07:34AM
Nov-11-21 07:05AM
Nov-04-21 07:05AM
Sep-28-21 03:33PM
Sep-08-21 07:05AM
Dogwood Therapeutics, Inc. is a development-stage biotechnology company, which engages in developing therapeutics for pain and fatigue illness. Its product includes Halneuron. It focuses on antiviral therapies IMC-1 and IMC-2 to treat diseases associated with a viral triggered abnormal immune response such as Long-COVID and fibromyalgia. The company was founded on February 28, 2012 is headquartered in Alpharetta, GA.